(Hypertension. 1999;34:1147-1151.)
© 1999 American Heart Association, Inc.
Scientific Contributions |
Orthostatic Stimuli Rapidly Change Plasma Adrenomedullin in Humans
From the Volume Regulation and Space Medicine Research Group, Department of Physiology, School of Medicine (A.R.), Karl-Franzens University, Graz, Austria; the Third Department of Medicine, Semmelweis University Medical School (Z.L.), Budapest, Hungary; and the Institute for Adaptive and Spaceflight Physiology (B.H., H.G.H-S.), Austrian Society for Aerospace Medicine, Graz, Austria.
Correspondence to Andreas Rössler, Department of Physiology, School of Medicine, Karl-Franzens University, Harrachgasse 21, A-8010 Graz, Austria. E-mail andreas.roessler{at}kfunigraz.ac.at
 |
Abstract |
|---|
 Top Abstract IntroductionMethodsResultsDiscussionReferences |
|---|
Abstract—The aim of this study was to evaluate the effect of orthostasis on the time course of plasma adrenomedullin concentration. On 5 different days, normotensive subjects were randomized to undergo for 30 minutes either 12°, 30°, 53°, or 70° passive head-up tilt or to remain supine. Venous blood was collected from each subject in the supine position before tilting, at 3 and 27 minutes during tilting, and at 2 and 50 minutes after orthostasis. Plasma adrenomedullin increased significantly with tilt of
30° in a stimulus-dependent manner. Approximately half
of the increase seen at 27 minutes occurred during the first 2 minutes
of upright positioning; the maximum effect with 70° tilt was +70%.
Elevations in norepinephrine, epinephrine,
aldosterone, plasma renin activity, vasopressin, heart
rate, and mean arterial pressure were also significant.
Hematocrit, blood density, plasma density, and plasma volume loss rose
(P<0.05) at 53° and 70° tilt. Our results indicate
that adrenomedullin may play an important role in stabilization of
hemodynamics during passive orthostasis. In conclusion,
plasma adrenomedullin rapidly increases with orthostatic
challenge in a stimulus-dependent manner and also swiftly returns to
baseline levels after the subject resumes the supine
position.
Key Words: tilt, head-up • adrenomedullin • barorereflex • volume, plasma • catecholamines
|
Introduction |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
The 52–amino acid peptide adrenomedullin (ADM) is a potent vasorelaxant1 and natriuretic2 peptide. The strong relationship between plasma ADM and vascular tone functions in water homeostasis by increasing the glomerular filtration rate and natriuresis while lessening renal vascular resistance.2 3 Additionally, ADM might function as an endothelium-derived relaxation factor and an autocrine or paracrine factor for vascular smooth muscle.4
Until now, no data were available on changes in plasma ADM levels induced by orthostasis, which redistributes blood from central- to lower-body vascular beds and unloads cardiopulmonary receptors5 ; this causes constriction of resistance and capacitance vessels,6 in part through the action of vasopressin, angiotensin, and endothelin-1.7 8
The present investigation was designed to test the hypothesis that plasma ADM is influenced by head-up tilting (HUT) in normotensive, euhydrated humans; to study the time course of ADM during and after HUT; and to quantify effects in relation to the intensity of orthostatic challenge. As ancillary information, hemodynamic and other endocrine as well as blood volume indicators were determined. The present study shows that ADM responds quickly and in a dose-dependent manner to HUT, and its concentration rapidly declines afterward.
|
Methods |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Subjects
Investigations were performed on 8 healthy, nonsmoking male volunteers (age, 24 to 38 years; weight, 62 to 75 kg; height, 170 to 180 cm; body surface area, 1.72 to 1.93 m2; body fat mass as estimated by bioelectrical impedance analysis single-frequency bioimpedance measurement, 13.6% to 17.6%; values are ranges) who had no history of syncopal or presyncopal episodes of vasovagal origin and were normotensive. Medical clearance to participate was required of all subjects and was based on medical history review, physical examination, and resting 12-lead ECG. Subjects abstained from medication, were fully informed about the purpose and nature of the experiments, and gave informed consent. The experimental protocol was approved by the local Institutional Ethics Committee.
Experimental Protocol
To compare dose-response traits in identical subjects, we used
12°, 30°, 53°, and 70° HUT (sin, 0.21, 0.50, 0.80, and 0.94,
respectively). The tilt table had a footboard and chest harness,
upright position was assumed within 20 s, and tilting lasted 30
minutes. All subjects underwent 5 experiments (4 HUT, 1 continuously
supine [rest control]), in randomized order on different test
days.
After a standardized breakfast (l00 g bread with butter and jam and 200 g orange juice), each experimental session began at 8:30 AM with a 40-minute supine rest period, during which the blood-pressure cuff was positioned and the left antecubital vein was cannulated with a 17-gauge 1.4x40-mm 3-way-stopcock Teflon catheter (TriCath In, Codan Steritex). Venous blood was poured into prechilled tubes containing EDTA and Trasylol (aprotinin; 500 kallikrein inhibition units [KIU]/mL for the samples of plasma ADM and arginine vasopressin [AVP]) and immediately placed on ice.
The arm was positioned such that the lower arm remained near the hydrostatic indifference point at any body posture. Blood samples were taken every minute to measure blood density, plasma density, and hematocrit at the beginning and end of orthostasis and for hormone determinations 10 minutes before orthostasis (10 minutes before tilt in the supine position [baseline]), at 3 and 27 minutes of HUT, and at 2 and 50 minutes after HUT in the supine position (minutes 32 and 80).
Data from actual HUT sessions were compared with rest control (HUT0) data at identical protocol times. Plasma samples prepared by instantaneous centrifugation were frozen at -20°C for hormone determinations.
Measurements
Blood pressure (systolic blood pressure, mean
arterial pressure, and diastolic blood
pressure; in mm Hg) was determined oscillometrically (Dinamap
1846 SX, Critikon) every 20 s. Hematocrit (Hct) was determined in
quadruplicate by microcentrifugation (10 minutes at
10 000 rpm) without correction for trapped plasma. Blood density (BD)
and plasma density (PD) were measured at 37.00±0.02°C with a
high-precision mass densitometry device (model DMA 602 M, Paar KG) on
0.2-mL samples using the mechanical oscillator technique,9
in which the resonant frequency of a U-shaped glass tube is determined
and converted to corresponding density values. Mass density (FD) of the
fluid shifted into or from the circulating blood was calculated from
corresponding PD and Hct values10 :
 |
 |
Hormone Measurements
Catecholamines were determined using high-pressure
liquid chromatography; all other hormones were measured
by radioimmunoassay. After blood samples were centrifuged at
2500 rpm at 4°C for 15 minutes, plasma was decanted and stored at
-80°C to await analysis. For ADM measurement, 2 mL of plasma
was extracted onto C-18 bond elute cartridges (Millipore-Waters) that
had been prewashed with methanol and saline (9 g/L) and eluted with
95% methanol containing 1% trifluoroacetic acid. Extraction
efficiency was measured by addition of labeled ADM; the calculated
recovery rate was 68.4%. Concentrated eluates were dried under air and
extracts stored at -20°C until the day of assay. Before measurement,
samples were reconstituted in radioimmunoassay buffer and the clear
solution tested in a single assay with a specific and sensitive
radioimmunoassay for ADM (Phoenix Pharmaceuticals). The antibody of
this assay does not crossreact with endothelin-1, calcitonin
gene—related peptide, atrial natriuretic peptide, brain
natriuretic peptide, or C-type natriuretic
peptide. Briefly, samples were incubated overnight with a specific
antibody reactive to human ADM (1-52) at 4°C.
125I-labeled ADM was added and incubated another
24 hours at 4°C. Free and bound fractions were separated by addition
of a second antibody and further centrifugation at 3000
rpm for 20 minutes at 4°C. Radioactivity was measured with a gamma
counter, and minimal detectable concentration for this assay was 0.5
pmol/L.
AVP was determined by a competitive radioimmunoassay (vasopressin; Nichols Institute Diagnostics) after prior ethanol extraction; recovery rate for the peptide after purification from binding proteins was 73.5%, and assay sensitivity was 1.2 pmol/L. Plasma renin activity was determined by radioimmunoassay of angiotensin-I (RENCTK; Sorin Biomedica) and expressed as nanograms of angiotensin-II formed per milliliter of plasma per hour of incubation (ng · mL-1 · h-1). Sensitivity (ie, the amount of analyte able to lower the binding ability by 2SD, was 0.13 ng/mL; within-assay and between-assay coefficients of variation were 7.6% and 9.1%, respectively. Aldosterone (AldoCTK-2; Sorin Biomedica) test sensitivity, defined as the apparent concentration of analyte that can be distinguished from the zero standard, was <56 pmol/L at 95% confidence limit, within-assay and between-assay coefficients of variation were 9.7% and 11.5%, respectively. Catecholamines were measured with high-pressure liquid chromatography (Hewlett Packard) using electrochemical detection (600 mV) after prior alumina (Al2O3) extraction (Chromsystems), and dihydroxybenzoic acid was used as the internal standard.11 After extraction was completed, 50 µL of eluent was injected into the high-pressure liquid chromatographic column (reverse-phase, LiChrosorb RP-18, Merck) eluted with mobile phase at a flow rate at 1.1 mL/min and integrated on the integration system.
Data Analysis
Data are presented as mean±SEM unless otherwise stated.
The Shapiro-Wilks W test indicated normal distribution of
all data. A 1-way ANOVA for repeated measurements was used to determine
the effect of time on variables and differences between test
conditions. Post-hoc Student’s paired t test compared HUT
and rest control data from identical protocol times. Differences were
considered significant if P<0.05 for the null hypothesis.
Data analysis was performed using the Statistica software set
(version 5.0, StatSoft, Inc).
For graphic presentation, data from 10 minutes before HUT of the experiment were taken as 100%, and all following data were expressed in normalized fashion. These relative values were also used to test differences between HUT and rest control. To calculate correlations between ADM and other variables from corresponding times, linear regression analysis was applied on the normalized (percentage of preHUT) data.
|
Results |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
All subjects stayed normotensive during HUT and completed the protocol (Table 1). Before HUT, systolic blood pressure averaged 103.2±1.2 and diastolic 51.2±1.7 mm Hg (average of all subjects and tilt levels pooled; n=40).
|
The relative changes in plasma ADM concentration during and after
different angles of HUT are shown in Figure 1. The mean plasma levels of ADM before
stimulus averaged 4.5±0.2 pmol/L (mean±SEM), increased during
sustained tilt, and returned within 50 minutes of recovery to pretilt
baseline levels. With HUT 30°, norepinephrine, AVP, and
ADM were significantly elevated; with HUT 53°,
aldosterone, plasma renin activity, and epinephrine
were elevated. Two minutes after HUT, plasma levels of ADM and
catecholamines were already lower than during tilt (Table 2). Plasma ADM and
catecholamines were linearly correlated
(epinephrine, R=0.902; P<0.0001;
norepinephrine, R=0.921; P<0.0001)
with pooled data from all levels of orthostatic
challenge (Figure 2).
Diastolic pressure and tilt angle were directly correlated
(Table 1), as were diastolic pressure and plasma ADM
(R=0.887; P<0.0001) (Figure 2). With
unchanged systolic pressure, this resulted in decreased pulse
pressure at HUT 53° and 70° (-4% and -10%). Heart rate
increased with degree of HUT, as did BD and PD; consequently, plasma
volume declined as expected (Table 3).
|
|
|
|
The density of fluid shifted (FD) was 1008.4±3.1 g/L as found in earlier tilt table experiments.9 There was a significant correlation (R=0.995) between plasma volume loss and ADM increase. 50 minutes after HUT, all variables returned to preHUT levels.
|
Discussion |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
ADM, a recently discovered multifunctional peptide with slight homology to calcitonin gene–related peptide and amylin, is conceivably involved in circulatory control as a result of its vasodilator and natriuretic activities.1 2 ADM mainly originates from the adrenal medulla, lung, and kidney, and to a lesser extent from the heart, spleen, duodenum, and submandibular glands.12 13 Plasma ADM levels are elevated with strenuous exercise14 and with heart failure, hypervolemia, and sympathetic activation; a counterregulatory role of ADM in terms of balancing peripheral vascular resistance elevation has been proposed.15 To our knowledge, only 1 study has yet examined the integrated hemodynamic and ADM time course during and after orthostatic stress in healthy humans.16
Tilting level and duration clearly influence the degree of thoracic blood volume, atrial diameter, and central venous pressure decrease in healthy young people,17 with commensurate increase in plasma catecholamines, renin-angiotensin-aldosterone, and occasionally vasopressin.18 Our results demonstrate that orthostasis elicits stimulus-dependent ADM increase as part of a "quick humoral response," along with epinephrine and norepinephrine. Even at 30° HUT (sin, 0.5), the effects were significant within 3 minutes. Furthermore, the post-HUT decrease of these hormones was likewise significant within 2 minutes (Table 2), which can be attributed to the short half-life of ADM of several minutes.19 20 This might indicate a symmetric function of ADM and catecholamines in terms of quick endocrine response to baroreceptor stimulation,21 which results in a fine-tuning of vascular diameter after postural changes.
The results of the present study complement those presented by Mallamaci et al,16 who did not find significant increases in ADM with tilting. Nevertheless, they also observed a rapid ADM increase within the first minutes of orthostasis with elevated levels throughout the entire HUT period. Basal vasopressin plasma levels were unusually high in their study, with a tilt-induced response 3 times higher than is usually seen with orthostasis. Thus, their subjects conceivably were dehydrated or orthostatically not fully competent, a condition likely to blunt ADM responses with HUT. Thus, our data are the first to present significant ADM effects with passive tilting in obviously euhydrated, normotensive, and orthostatic stable subjects. The observed blood pressures of our subjects are in the lower range (Table 1), which is consistent with the 40-minute supine resting preHUT period established to reach blood pressure equilibrium and with the fact that the subjects were familiar with the experimental procedure from earlier, similar experiments.
Direct interactions of ADM with other hormones and autonomous nerve have been demonstrated. ADM inhibits renal sympathetic nerve activity while increasing renin output in a paracrine fashion, which influences both renin gene expression and secretion.22 23 24 Furthermore, ADM triggers adrenal catecholamine release and enhances cardiac contractility via cAMP-independent mechanisms.25 26 ADM may in fact buffer the sympathetic response to tilting, thereby dampening baroreflex effects23 and counteracting further blood pressure elevation.27 It remains to be clarified which of the various cardiovascular effects of ADM prevail under physiological circumstances of orthostatic challenging.
In conclusion, plasma ADM rapidly changes during and after various degrees of HUT in humans, which suggests quick and sensitive baroreceptor-driven secretion. This complements findings of previous investigations14 16 and suggests that ADM plays an important role in cardiovascular regulatory stability in concert with other hormonal mechanisms.
|
Acknowledgments |
|---|
We thank Ulrike Wöllik and Andreas Rothaler for their excellent technical support. This study was supported by the Austrian Research Fund (P11531 MED), the Austrian Ministry for Sciences and Research (BMWF), and the Austrian Society for Aerospace Medicine (ASM), Vienna, Austria.
Received May 14, 1999; first decision June 1, 1999; accepted June 21, 1999.
|
References |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
- Nuki C, Kawasaki H, Kitamura K, Takenaga M, Kangawa K, Eto T, Wada A. Vasodilator effect of adrenomedullin and calcitonin gene-related peptide receptors in rat mesenteric vascular beds. Biochem Biophys Res Commun.. 1993;196:245–251.[Medline] [Order article via Infotrieve]
-
Hirata Y, Hayakawa H, Suzuki Y, Ikenouchi H, Kohmoto
O, Kimura K, Eto T, Kangawa K, Matsuo H, Omata M. Mechanism of
adrenomedullin-induced vasodilation in the rat kidney.
Hypertension.. 1995;25:790–795.
[Abstract/Free Full Text] - Sugo S, Minamino N, Kangawa K, Miyamoto K, Kitamura K, Sakata J, Eto T. Endothelial cells activity synthesize and secrete adrenomedullin. Biochem Biophys Res Commun. 1994;201:1160–1166.[Medline] [Order article via Infotrieve]
- Ishizaka Y, Tanaka M, Kitamura K, Kangawa K, Minamino N, Matsuo H, Eto T. Adrenomedullin stimulates cyclic AMP formation in rat vascular smooth muscle cells. Biochem Biophys Res Commun. 1994;200:642–646.[Medline] [Order article via Infotrieve]
- Berdeaux A, Duranteau J, Pussard E, Edouard A, Giudicelli JF. Baroreflex control of regional vascular resistances during simulated orthostatism. Kidney Int Suppl. 1992;37:29–33.
- Perko MJ, Madsen P, Perko G, Schroeder TV, Secher NH. Mesenteric artery response to head-up tilt-induced central hypovolaemia and hypotension. Clin Physiol. 1997;17:487–496.[Medline] [Order article via Infotrieve]
-
Sander-Jensen K, Secher NH, Astrup A, Christensen NJ,
Giese J, Schwartz TW, Warberg J, Bie P. Hypotension induced by passive
head-up tilt: endocrine and circulatory mechanisms. Am J
Physiol. 1986;251:R742–R748.
[Abstract/Free Full Text] - Matzen S, Emmeluth C, Milliken MC, Secher NH. Plasma endothelin-1 during central hypovolaemia in man. Clin Physiol. 1992;12:653–658.[Medline] [Order article via Infotrieve]
-
Hinghofer-Szalkay H. Method of high-precision
microsample blood and plasma densitometry. J Appl
Physiol. 1986;60:1082–1088.
[Abstract/Free Full Text] -
Hinghofer-Szalkay H, Sauseng-Fellegger G, Greenleaf JE.
Plasma volume with alternating tilting: effect of fluid
ingestion. J Appl Physiol.. 1995;78:1369–1373.
[Abstract/Free Full Text] - Pluto R, Bürger P. Normal values of catecholamines in blood plasma determined by HPLC with amperometric detection. Int J Sports Med. 1988;9:75–78.
- Ichiki Y, Kitamura K, Kangawa K, Kawamoto M, Matsuo H, Eto T. Distribution and characterization of immunoreactive adrenomedullin in human tissue and plasma. FEBS Lett. 1994;338:6–10.[Medline] [Order article via Infotrieve]
- Kitamura K, Sakata J, Kangawa K, Kojima M, Matsuo H, Eto T. Cloning and characterization of DNA encoding a precursor for human adrenomedullin. Biochem Biophys Res Commun.. 1993;194:720–725.[Medline] [Order article via Infotrieve]
- Tanaka M, Kitamura K, Ishizaka Y, Ishiyama Y, Kato J, Kangawa K, Eto T. Plasma adrenomedullin in various diseases and exercise-induced change in adrenomedullin in healthy subjects. Intern Med. 1995;34:728–733.[Medline] [Order article via Infotrieve]
- Kato J, Kobayashi K, Etoh T, Tanaka M, Kitamura K, Imamura T, Koiwaya Y, Kangawa K, Eto T. Plasma adrenomedullin concentration in patients with heart failure. J Clin Endocrinol Metab. 1996;81:180–183.[Abstract]
- Mallamaci F, Zoccali C, Parlongo S, Cutrupi S, Triperi G, Postorino M. Plasma adrenomedullin during acute changes in intravascular volume in hemodialysis patients. Kidney Int. 1998;54:1697–1703.[Medline] [Order article via Infotrieve]
- Musgrave FS, Zechman FW, Mains RC. Comparison of the effects of 70° tilt and several levels of lower body negative pressure on heart rate and blood pressure in man. Aerospace Med. 1971;42:1065–1069.[Medline] [Order article via Infotrieve]
- Harrison MH, Geelen G, Keil LC, Wade CA, Hill LC, Kravik SE, Greenleaf JE. Effect of hydration on plasma vasopressin, renin, and aldosterone responses to head-up tilt. Aviat Space Environ Med. 1986;57:420–425.[Medline] [Order article via Infotrieve]
- Ishiyama Y, Sakata J, Kitamura K, Ichiki Y, Nakamura S, Eto T. Hypotensive action and kinetics of adrenomedullin in rats. Jpn Circ J. 1994;58:291.
-
Meeran K, O’Shea D, Upton PD, Small CJ, Ghatei MA,
Byfield PH, Bloom SR. Circulating adrenomedullin does not regulate
systemic blood pressure but increases plasma prolactin after
intravenous infusion in humans: a pharmacokinetic study.
J Clin Endocrinol Metab. 1997;82:95–100.
[Abstract/Free Full Text] - Jacobs MC, Goldstein DS, Willemsen JJ, Smits P, Thien T, Lenders JWM. Differential effects of low- and high-intensity lower body negative pressure on noradrenaline and adrenaline kinetics in humans. Clin Sci. 1996;90:337–343.[Medline] [Order article via Infotrieve]
-
Charles CJ, Rademaker MT, Richards AM, Cooper GJS, Coy
DH, Jing N, Nicholls MG. Hemodynamic, hormonal, and
renal effects of adrenomedullin in conscious sheep. Am J
Physiol. 1997;272:R2040–R2047.
[Abstract/Free Full Text] -
Fukuhara M, Tsuchihashi T, Abe I, Fujishima M.
Cardiovascular and neurohumoral effects of
intravenous adrenomedullin in conscious rabbits.
Am J Physiol. 1995;269:R1289–R1293.
[Abstract/Free Full Text] -
Jensen BL, Krämer BK, Kurtz A. Adrenomedullin
stimulates renin release and renin mRNA in mouse
juxtaglomerular granular cells. Hypertension. 1997;29:1148–1155.
[Abstract/Free Full Text] - Ishimitsu T, Nishikimi T, Saito Y, Kitamura K, Eto T, Kangawa K, Matsuo H, Omae T, Matsuoka H. Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure. J Clin Invest.. 1994;94:2158–2161.
-
Szokodi I, Kinnunen P, Tavi P, Weckstrom M, Toth M,
Ruskoaho H. Evidence for cAMP-independent mechanisms mediating the
effects of adrenomedullin, a new inotropic peptide.
Circulation. 1998;97:1062–1070.
[Abstract/Free Full Text] - Okamura T, Zhang JX, Kangawa K, Toda N. Inhibition by adrenomedullin of the adrenergic neurogenic response in canine mesenteric arteries. Jpn J Pharmacol.. 1997;73:259–261.[Medline] [Order article via Infotrieve]
This article has been cited by other articles:
 |
|
 |
|
  H. G. Hinghofer-Szalkay, A. Rossler, J. M. Evans, M. B. Stenger, F. B. Moore, and C. F. Knapp Circulatory galanin levels increase severalfold with intense orthostatic challenge in healthy humans J Appl Physiol, March 1, 2006; 100(3): 844 - 849. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. P. Tulppo, R. L. Hughson, T. H. Makikallio, K. E. J. Airaksinen, T. Seppanen, and H. V. Huikuri Effects of exercise and passive head-up tilt on fractal and complexity properties of heart rate dynamics Am J Physiol Heart Circ Physiol, March 1, 2001; 280(3): H1081 - H1087. [Abstract] [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||